By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AdAlta Pty Ltd. 

15/2 Park Drive

Bundoora   Victoria  3083  Australia
Phone: 92-120-332-925 Fax: 61-3-9479-5159


SEARCH JOBS


Industry
Biotechnology






Company News
AdAlta Pty Ltd. Release: Pharma Receives Orphan Designation For Its Lead Drug Candidate Targeting Patients With Idiopathic Pulmonary Disease 1/18/2017 9:20:33 AM
AdAlta Pty Ltd. Announces Positive Pre-clinical Data Showing Lead Drug Candidate Has Broad Fibrosis Treatment Potential 1/9/2017 11:05:47 AM
AdAlta Pty Ltd. Extends Board With Appointment Of US-Based Non Executive Director 12/19/2016 8:49:31 AM
AdAlta Pty Ltd. Licenses Alzheimer's Disease-Specific Shark Antibodies To Crossbeta Biosciences B.V. For Therapeutic And Diagnostic Development 11/8/2016 10:37:08 AM
AdAlta Pty Ltd. And XL-Protein Announce Collaboration To Develop A Long Acting Version Of Its Lead Fibrosis Drug Candidate AD-114 Using Pasylation Technology 11/7/2016 9:48:36 AM
AdAlta Pty Ltd. To Present At Forthcoming Industry Conferences 10/19/2016 9:51:10 AM
AdAlta Pty Ltd. Update On Orphan Drug Designation Application For Lead Drug Targeting Idiopathic Pulmonary Fibrosis 10/14/2016 9:51:54 AM
AdAlta Pty Ltd. To Present At Two New Drug Therapy Conferences Next Week 9/16/2016 9:55:01 AM
AdAlta Pty Ltd. Signs Agreement With Fujifilm Diosynth Biotechnologies To Begin Manufacturing Its Lead Fibrosis Drug Candidate 9/12/2016 10:23:34 AM
AdAlta Pty Ltd. Receives Australian Government Grant To Advance Understanding Of Potential New Lung Fibrosis Therapy 8/31/2016 9:43:20 AM
12
//-->